Tackling Bleeding - One Appendage at a Time.
作者信息
Garzon Stefano, Bandeira Willterson Carlos
机构信息
Hospital Israelita Albert Einstein - Cardiologia Intervencionista, São Paulo, SP - Brasil.
Irmandade da Santa Casa de Misericórdia de São Paulo - Cardiologia Intervencionista, São Paulo, SP - Brasil.
出版信息
Arq Bras Cardiol. 2022 Jul;119(1):57-58. doi: 10.36660/abc.20220351.
Abstract
摘要
相似文献
1
Tackling Bleeding - One Appendage at a Time.一次处理一个部位的出血问题。
Arq Bras Cardiol. 2022 Jul;119(1):57-58. doi: 10.36660/abc.20220351.
2
Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology: Final 2-Year Outcome Data of the EWOLUTION Trial Focusing on History of Stroke and Hemorrhage.评估接受 WATCHMAN 左心耳封堵技术的房颤患者的真实世界临床结局：EWOLUTION 试验的最终 2 年结局数据，重点关注卒中史和出血史。
Circ Arrhythm Electrophysiol. 2019 Apr;12(4):e006841. doi: 10.1161/CIRCEP.118.006841.
3
Reduction in risk of stroke and bleeding after left atrial appendage closure with LARIAT device in patients with increased risk of stroke and bleeding: Long term results.左心耳封堵术 LARIAT 装置降低高卒中出血风险患者的卒中及出血风险：长期结果。
Catheter Cardiovasc Interv. 2019 Nov 15;94(6):837-842. doi: 10.1002/ccd.28187. Epub 2019 Mar 18.
4
Bleeding Outcomes After Left Atrial Appendage Closure Compared With Long-Term Warfarin: A Pooled, Patient-Level Analysis of the WATCHMAN Randomized Trial Experience.左心耳封堵术后与长期华法林治疗的出血结局比较：WATCHMAN 随机试验经验的患者水平汇总分析。
JACC Cardiovasc Interv. 2015 Dec 28;8(15):1925-1932. doi: 10.1016/j.jcin.2015.08.035. Epub 2015 Nov 25.
5
Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.左心耳封堵术与直接口服抗凝剂在伴有心房颤动的高危患者中的比较。
J Am Coll Cardiol. 2020 Jun 30;75(25):3122-3135. doi: 10.1016/j.jacc.2020.04.067.
6
The Amplatzer Amulet Device: Technical Considerations and Procedural Approach.Amplatzer Amulet封堵器：技术考量与操作方法
Interv Cardiol Clin. 2018 Apr;7(2):213-218. doi: 10.1016/j.iccl.2017.12.012.
7
Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.经皮左心耳封堵术预防高卒中及出血风险房颤患者血栓栓塞事件的疗效与安全性。
Clin Res Cardiol. 2016 Mar;105(3):225-9. doi: 10.1007/s00392-015-0910-8. Epub 2015 Aug 30.
8
Left atrial appendage closure for prevention of death, stroke, and bleeding in patients with nonvalvular atrial fibrillation.左心耳封堵术预防非瓣膜性心房颤动患者的死亡、卒中和出血。
Int J Cardiol. 2017 Dec 15;249:234-246. doi: 10.1016/j.ijcard.2017.08.049. Epub 2017 Aug 26.
9
10
Airway Hemorrhage During Left Atrial Appendage Exclusion Device Insertion.
J Cardiothorac Vasc Anesth. 2022 Aug;36(8 Pt B):3124-3128. doi: 10.1053/j.jvca.2021.10.040. Epub 2021 Nov 2.
本文引用的文献
1
Left Atrial Appendage Closure with the LAmbre Device - Initial Multicentre Experience in Brazil.使用LAmbre封堵器进行左心耳封堵术——巴西的初步多中心经验
Arq Bras Cardiol. 2022 Jul;119(1):48-56. doi: 10.36660/abc.20210275.
2
Value of left atrial diameter with CHA2DS2-VASc score in predicting left atrial/left atrial appendage thrombosis in non-valvular atrial fibrillation.左房直径联合 CHA2DS2-VASc 评分预测非瓣膜性心房颤动患者左房/左心耳血栓的价值。
Arq Bras Cardiol. 2021 Feb;116(2):325-331. doi: 10.36660/abc.20190492.
3
Clinical Outcomes Associated With Left Atrial Appendage Occlusion Versus Direct Oral Anticoagulation in Atrial Fibrillation.左心耳封堵与直接口服抗凝药在房颤中的临床结局比较。
JACC Cardiovasc Interv. 2021 Jan 11;14(1):69-78. doi: 10.1016/j.jcin.2020.09.051.
4
The NCDR Left Atrial Appendage Occlusion Registry.NCDR 左心耳封堵器械注册研究。
J Am Coll Cardiol. 2020 Apr 7;75(13):1503-1518. doi: 10.1016/j.jacc.2019.12.040.
5
Stroke Risk as a Function of Atrial Fibrillation Duration and CHADS-VASc Score.房颤持续时间和 CHADS-VASc 评分与卒中风险的关系。
Circulation. 2019 Nov 12;140(20):1639-1646. doi: 10.1161/CIRCULATIONAHA.119.041303. Epub 2019 Sep 30.
6
Anticoagulation Bridge Therapy in Patients with Atrial Fibrillation: Recent Updates Providing a Rebalance of Risk and Benefit.心房颤动患者的抗凝桥接治疗：提供风险与获益再平衡的最新进展
Pharmacotherapy. 2017 Jun;37(6):712-724. doi: 10.1002/phar.1937. Epub 2017 Jun 6.
7
Predictive ability of HAS-BLED, HEMORR2HAGES, and ATRIA bleeding risk scores in patients with atrial fibrillation. A French nationwide cross-sectional study.HAS-BLED、HEMORR2HAGES和ATRIA出血风险评分对房颤患者的预测能力。一项法国全国性横断面研究。
Int J Cardiol. 2016 Aug 15;217:85-91. doi: 10.1016/j.ijcard.2016.04.173. Epub 2016 May 3.
8
The HAS-BLED Score for Predicting Major Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: A Systematic Review and Meta-analysis.用于预测心房颤动抗凝患者大出血风险的HAS - BLED评分：一项系统评价和荟萃分析。
Clin Cardiol. 2015 Sep;38(9):555-61. doi: 10.1002/clc.22435.
9
Performance of the HAS-BLED high bleeding-risk category, compared to ATRIA and HEMORR2HAGES in patients with atrial fibrillation: a systematic review and meta-analysis.与ATRIA和HEMORR2HAGES相比，房颤患者中HAS-BLED高出血风险分类的表现：一项系统评价和荟萃分析。
J Interv Card Electrophysiol. 2014 Sep;40(3):277-84. doi: 10.1007/s10840-014-9930-y. Epub 2014 Jul 11.
10
Apixaban versus warfarin in patients with atrial fibrillation.阿哌沙班与华法林用于房颤患者。
N Engl J Med. 2011 Sep 15;365(11):981-92. doi: 10.1056/NEJMoa1107039. Epub 2011 Aug 27.
Zotero 插件